Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (5): 546-550.

Previous Articles     Next Articles

Tolerability research of single dose of iptakalim hydrochloride in healthy Chinese volunteers

FANG Yi1,2, WANG Rui3, CHAI Dong3, CUI Wen-yu4, WANG Hai4, GUAN Hua-shi1   

  1. 1Institute of Marine Drug &Food of OceanUniversity of China, Qingdao 266003, Shandong, China;
    2Department of Pharmacy, Peking University People's Hospital, Beijing 100044, China;
    3Department of Clinical Pharmacology, Chinese PLAGeneral Hospital, Beijing 100853, China;
    4Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China
  • Received:2009-01-23 Revised:2009-04-03 Published:2020-11-09

Abstract: AIM:To evaluate the safety and tolerability of single dose of iptakalim hydrochloride in healthy Chinese volunteers. METHODS:52 healthy volunteers in 18-50 years old were chosen and randomized into 6 dose groups, including 2. 5, 5, 10, 15, 20, 25 mg. Group B, C, D, E contained 10 volunteers respectively, and Group A and F contained 6 volunteers. Each group contained 2 volunteers (1 male and 1 female)who were administrated with placebo. Clinical symptoms, vital signs, the changes of laboratory examination indexes, and all adverse drug events were observed. RESULTS:After single dose of 2. 5-25mg, the clinical symptoms, vital signs and index of laboratory examination were in normal range. There were no severe adverse events, and no adverse events were related to the drug. CONCLUSION:The single-dose of iptakalim hydrochloride range from 2. 5 mg to 25 mg in healthy Chinese volunteers were safe and tolerable in 52 healthy Chinese volunteers.

Key words: iptakalim hydrochloride, safety, tolerability

CLC Number: